The tennis champion invested in 2020 with his wife Jelena in QuantBioRes, a Danish company that seeks to develop a treatment for Covid-19. The Djokovic couple owns 80% of the biotech.
Ivan Loncarevic, director of QuantBioRes, has enlisted the help of tennis star Novak Djokovic. The investment will be made in June 2020. The former world number one tennis player and his wife, Jelena Djokovic, each own 40.80% and 39.20% of the Danish biotech company, which means that they own 80% of the company. QuantBioRes employs around 20 people in Denmark, Slovenia, Australia, and the UK. The treatment developed by the biotech is a peptide that would prevent the coronavirus from infecting human cells. The company uses a novel resonant recognition model (RRM). Covid-19 is just a launch pad for the company, which aspires to treat all other viruses.
A fortune estimated at over 200 million
Novak Djokovic’s fortune is now estimated at over $200 million, making him one of the richest sportsmen in the world. Djokovic has made numerous investments in companies. In addition to his professional earnings, the Serbian star owes his immense fortune to stock market investments but also to a substantial real estate portfolio and very lucrative advertising contracts, notably with CoverGirl cosmetics. He also owns several restaurants in Belgrade, a football club in Belgrade, and is said to be involved in teenage fashion with a clothing line, “Djokovic Séduction,” and a perfume, “L’eau de Novak”!
